Analyst Price Target is $4.13
▲ +2.61% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for KORU Medical Systems in the last 3 months. The average price target is $4.13, with a high forecast of $5.00 and a low forecast of $3.50. The average price target represents a 2.61% upside from the last price of $4.02.
Current Consensus is
Buy
The current consensus among 4 polled investment analysts is to buy stock in KORU Medical Systems. This Buy consensus rating has held steady for over two years.
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Read More